Ke Li
- Biomedical Engineering top 1%
- Biomaterials top 1%
- Molecular Biology top 10%
- Materials Chemistry top 10%
- Immunology top 5%
- Topics
- Nanoplatforms for cancer theranostics (25 papers)Nanoparticle-Based Drug Delivery (15 papers)Microfluidic and Bio-sensing Technologies (10 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Ke Li
80 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Biomedical Engineering 1.8k
- Biomaterials 817
- Molecular Biology 803
- Materials Chemistry 659
- Immunology 466
Countries citing papers authored by Ke Li
This map shows the geographic impact of Ke Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Li more than expected).
Fields of papers citing papers by Ke Li
This network shows the impact of papers produced by Ke Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Li. The network helps show where Ke Li may publish in the future.
Co-authorship network of co-authors of Ke Li
This figure shows the co-authorship network connecting the top 25 collaborators of Ke Li. A scholar is included among the top collaborators of Ke Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Li. Ke Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 55 | |
| 5 | Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancerbreakdown → | 94 |
| 6 | 11 | |
| 7 | 28 | |
| 8 | 94 | |
| 9 | 8 | |
| 10 | 6 | |
| 11 | 49 | |
| 12 | 81 | |
| 13 | 23 | |
| 14 | 33 | |
| 15 | 133 | |
| 16 | 30 | |
| 17 | 35 | |
| 18 | 99 | |
| 19 | 177 | |
| 20 | 42 |
About Ke Li
Ke Li is a scholar working on Biomaterials, Biomedical Engineering and Immunology, having authored 89 papers that have together received 3.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (15 papers) and Microfluidic and Bio-sensing Technologies (10 papers). The work is most often cited by research in Biomaterials (817 citations), Biomedical Engineering (1.8k citations) and Rehabilitation (164 citations). Ke Li has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Kaiyong Cai, Zhong Luo, Ye He, Lu Lu, Chuanchuan Lin, Bailong Tao, Liangliang Dai, Menghuan Li, Zengzilu Xia and Yulan Mao. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.